These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1280849)

  • 21. Serum amyloid P immunoreactivity in hippocampal tangles, plaques and vessels: implications for leakage across the blood-brain barrier in Alzheimer's disease.
    Kalaria RN; Grahovac I
    Brain Res; 1990 May; 516(2):349-53. PubMed ID: 2364299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multifaceted anti-amyloidogenic and pro-amyloidogenic effects of C-reactive protein and serum amyloid P component in vitro.
    Ozawa D; Nomura R; Mangione PP; Hasegawa K; Okoshi T; Porcari R; Bellotti V; Naiki H
    Sci Rep; 2016 Jul; 6():29077. PubMed ID: 27380955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of novel proteins associated with secondary amyloidosis and Alzheimer's disease by monoclonal antibody.
    Yamashita T; Imai K; Saito N; Yachi A
    Brain Res; 1988 Dec; 474(2):309-15. PubMed ID: 3208135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyloid and immune homeostasis.
    Wang YH; Zhang YG
    Immunobiology; 2018 Mar; 223(3):288-293. PubMed ID: 29070439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do extracellular chaperone proteins in plasma have potential as Alzheimer's disease biomarkers?
    Thambisetty M
    Biomark Med; 2010 Dec; 4(6):831-4. PubMed ID: 21133702
    [No Abstract]   [Full Text] [Related]  

  • 26. Endotoxin-like effects in acute phase response to Trypanosoma brucei brucei infection are not due to gastrointestinal leakage.
    Ngure RM; Eckersall P; Burke J; Karori SM; Mwangi WW; Wachira FN; Maathai R; Murray M
    Parasitol Int; 2009 Dec; 58(4):325-9. PubMed ID: 19567273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activated microglia and cerebral amyloid deposits in Alzheimer's disease.
    Rozemuller JM; van der Valk P; Eikelenboom P
    Res Immunol; 1992; 143(6):646-9. PubMed ID: 1455057
    [No Abstract]   [Full Text] [Related]  

  • 28. Human amyloidosis, Alzheimer disease and related disorders.
    Castaño EM; Frangione B
    Lab Invest; 1988 Feb; 58(2):122-32. PubMed ID: 3276958
    [No Abstract]   [Full Text] [Related]  

  • 29. The acute phase protein response in mice does not show tolerance to recurrent sterile inflammation.
    Todd NJ; Whicher JT; Westacott C; Gilbert A
    Clin Chim Acta; 1990 Jul; 189(1):47-54. PubMed ID: 1696529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloidosis and the acute phase response.
    Sipe JD
    Folia Histochem Cytobiol; 1992; 30(4):171-3. PubMed ID: 1303896
    [No Abstract]   [Full Text] [Related]  

  • 31. Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis.
    Pepys MB; Herbert J; Hutchinson WL; Tennent GA; Lachmann HJ; Gallimore JR; Lovat LB; Bartfai T; Alanine A; Hertel C; Hoffmann T; Jakob-Roetne R; Norcross RD; Kemp JA; Yamamura K; Suzuki M; Taylor GW; Murray S; Thompson D; Purvis A; Kolstoe S; Wood SP; Hawkins PN
    Nature; 2002 May; 417(6886):254-9. PubMed ID: 12015594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HDL, PTX3, and vascular protection.
    Mallat Z; Tedgui A
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):809-11. PubMed ID: 18421007
    [No Abstract]   [Full Text] [Related]  

  • 33. A case of familial, atypical Alzheimer's disease: immunohistochemical study of amyloid P-component.
    Iseki E; Amano N; Matsuishi T; Yokoi S; Arai N; Yagishita S
    Neuropathol Appl Neurobiol; 1988; 14(2):169-74. PubMed ID: 3399025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The in vitro neuronal toxicity of pentraxins associated with Alzheimer's disease brain lesions.
    Duong T; Acton PJ; Johnson RA
    Brain Res; 1998 Dec; 813(2):303-12. PubMed ID: 9838173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain amyloid in normal aging and cerebral amyloid angiopathy is antigenically related to Alzheimer's disease beta-protein.
    Coria F; Castaño EM; Frangione B
    Am J Pathol; 1987 Dec; 129(3):422-8. PubMed ID: 3322021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The involvement of astrocytes and an acute phase response in the amyloid deposition of Alzheimer's disease.
    Potter H
    Prog Brain Res; 1992; 94():447-58. PubMed ID: 1287729
    [No Abstract]   [Full Text] [Related]  

  • 37. [AA Amyloidosis: recent knowledges on pathophysiology].
    Magy N
    Rev Med Interne; 2004 Feb; 25(2):129-34. PubMed ID: 14744643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The presence of complements in amyloid plaques of Creutzfeldt-Jakob disease and Gerstmann-Straussler-Scheinker disease.
    Ishii T; Haga S; Yagishita S; Tateishi J
    Appl Pathol; 1984; 2(6):370-9. PubMed ID: 6400466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Basement membrane and beta amyloid fibrillogenesis in Alzheimer's disease.
    Inoue S
    Int Rev Cytol; 2001; 210():121-61. PubMed ID: 11580205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute phase response in mice experimentally infected with Trypanosoma congolense: a molecular gauge of parasite-host interaction.
    Ngure RM; Eckersall PD; Jennings FW; Mburu J; Burke J; Mungatana N; Murray M
    Vet Parasitol; 2008 Jan; 151(1):14-20. PubMed ID: 18063482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.